These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 18401552)

  • 1. Intravitreal bevacizumab (Avastin) as primary and rescue treatment for choroidal neovascularization secondary to ocular toxoplasmosis.
    Ben Yahia S; Herbort CP; Jenzeri S; Hmidi K; Attia S; Messaoud R; Khairallah M
    Int Ophthalmol; 2008 Aug; 28(4):311-6. PubMed ID: 18401552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravitreal ranibizumab for the treatment of choroidal neovascularization secondary to ocular toxoplasmosis.
    Shah NJ; Shah UN
    Indian J Ophthalmol; 2011; 59(4):318-9. PubMed ID: 21666322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary intravitreal bevacizumab for subfoveal choroidal neovascularization in age-related macular degeneration: results of the Pan-American Collaborative Retina Study Group at 12 months follow-up.
    Arevalo JF; Fromow-Guerra J; Sanchez JG; Maia M; Berrocal MH; Wu L; Saravia MJ; Costa RA;
    Retina; 2008; 28(10):1387-94. PubMed ID: 18827735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravitreal bevacizumab for choroidal neovascularization secondary to presumed ocular histoplasmosis syndrome.
    Ehrlich R; Ciulla TA; Maturi R; Kheradiya NS; Hrisomalos N; Shulman S; Guess MG; Coyle E; Harris A
    Retina; 2009; 29(10):1418-23. PubMed ID: 19898179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravitreal bevacizumab as initial treatment for choroidal neovascularization associated with presumed ocular histoplasmosis syndrome.
    Adán A; Navarro M; Casaroli-Marano RP; Ortiz S; Molina JJ
    Graefes Arch Clin Exp Ophthalmol; 2007 Dec; 245(12):1873-5. PubMed ID: 17786466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravitreal bevacizumab injection in patients with choroidal neovascularization due to choroid rupture after blunt-head trauma.
    Artunay O; Rasier R; Yuzbasioglu E; Sengül A; Bahcecioglu H
    Int Ophthalmol; 2009 Aug; 29(4):289-91. PubMed ID: 18825317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravitreal bevacizumab for treatment of choroidal neovascularization secondary to toxoplasmic retinochoroiditis: a case series.
    Kianersi F; Naderi Beni A; Naderi Beni Z; Ghanbari H
    Semin Ophthalmol; 2015 May; 30(3):181-7. PubMed ID: 24175641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravitreal injection of bevacizumab combined with verteporfin photodynamic therapy for choroidal neovascularization in age-related macular degeneration.
    Smith BT; Dhalla MS; Shah GK; Blinder KJ; Ryan EH; Mittra RA
    Retina; 2008 May; 28(5):675-81. PubMed ID: 18463509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravitreal bevacizumab (Avastin) in choroidal neovascular membrane in angioid streaks.
    Sachdev N; Vishwanathan K; Gupta V; Singh R; Gupta A
    Indian J Ophthalmol; 2007; 55(6):457-8. PubMed ID: 17951904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Laser photocoagulation, photodynamic therapy, and intravitreal bevacizumab for the treatment of juxtafoveal choroidal neovascularization secondary to pathologic myopia.
    Parodi MB; Iacono P; Papayannis A; Sheth S; Bandello F
    Arch Ophthalmol; 2010 Apr; 128(4):437-42. PubMed ID: 20142520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravitreal bevacizumab for the treatment of feeder vessel of subfoveal choroidal neovascularization.
    Theodossiadis PG; Grigoropoulos VG; Emfietzoglou I; Vergados J; Chalkiadakis J; Theodossiadis GP
    Eur J Ophthalmol; 2007; 17(5):853-6. PubMed ID: 17932868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravitreal bevacizumab for parafoveal telangiectasia-associated choroidal neovascular membrane.
    Shanmugam MP; Mythri HM; Shetty NS
    Indian J Ophthalmol; 2007; 55(6):490-1. PubMed ID: 17951923
    [No Abstract]   [Full Text] [Related]  

  • 13. Intravitreal bevacizumab for myopic choroidal neovascularization.
    Rensch F; Spandau UH; Schlichtenbrede F; von Baltz S; Libondi T; Jonas JB; Vossmerbaeumer U
    Ophthalmic Surg Lasers Imaging; 2008; 39(3):182-5. PubMed ID: 18556936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination photodynamic therapy and bevacizumab for choroidal neovascularization associated with toxoplasmosis.
    Rishi P; Venkataraman A; Rishi E
    Indian J Ophthalmol; 2011; 59(1):62-4. PubMed ID: 21157079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravitreal bevacizumab for the treatment of choroidal neovascularization associated with pathological myopia.
    Rhéaume MA; Sebag M
    Can J Ophthalmol; 2008 Oct; 43(5):576-80. PubMed ID: 18982035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Results of 1-year follow-up examinations after intravitreal bevacizumab administration for idiopathic choroidal neovascularization.
    Inoue M; Kadonosono K; Watanabe Y; Sato S; Kobayashi S; Yamane S; Ito R; Arakawa A
    Retina; 2010 May; 30(5):733-8. PubMed ID: 20168271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravitreal bevacizumab for previously treated choroidal neovascularization from age-related macular degeneration.
    Goff MJ; Johnson RN; McDonald HR; Ai E; Jumper JM; Fu A
    Retina; 2007; 27(4):432-8. PubMed ID: 17420694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravitreal bevacizumab (Avastin) as primary treatment for myopic choroidal neovascularization.
    Mandal S; Venkatesh P; Sampangi R; Garg S
    Eur J Ophthalmol; 2007; 17(4):620-6. PubMed ID: 17671940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dramatic response of choroidal neovascularization associated with choroidal osteoma to the intravitreal injection of bevacizumab (Avastin).
    Ahmadieh H; Vafi N
    Graefes Arch Clin Exp Ophthalmol; 2007 Nov; 245(11):1731-3. PubMed ID: 17653753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravitreally administered bevacizumab (Avastin) in minimally classic and occult choroidal neovascularization secondary to age-related macular degeneration.
    Lazic R; Gabric N
    Graefes Arch Clin Exp Ophthalmol; 2007 Jan; 245(1):68-73. PubMed ID: 17111146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.